Outpatient PE Management — RACP Adult Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Outpatient management with apixaban or rivaroxaban
Low-risk PE (sPESI 0 or PESI class I–II) in haemodynamically stable patients can be managed as outpatients with a DOAC (apixaban: 10 mg BD for 7 days then 5 mg BD; or rivaroxaban: 15 mg BD for 3 weeks then 20 mg daily). The Hestia criteria and sPESI score guide outpatient eligibility. Requirements include: no haemodynamic instability, no high bleeding risk, no need for supplemental oxygen, adequate social support, and reliable follow-up. The OCP should be permanently ceased and an alternative non-oestrogen contraceptive recommended.
Reference: eTG – 2025 – Haematology; ESC – 2019 – PE Guidelines